Fisher & Paykel Healthcare マネジメント
マネジメント 基準チェック /34
Fisher & Paykel Healthcareの CEO はLewis Gradonで、 Apr2016年に任命され、 の在任期間は 8.58年です。 の年間総報酬はNZ$ 3.53Mで、 50.6%給与と49.4%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.098%を直接所有しており、その価値はNZ$ 21.81M 。経営陣と取締役会の平均在任期間はそれぞれ3.5年と4.5年です。
主要情報
Lewis Gradon
最高経営責任者
NZ$3.5m
報酬総額
| CEO給与比率 | 50.6% |
| CEO在任期間 | 8.6yrs |
| CEOの所有権 | 0.1% |
| 経営陣の平均在職期間 | 3.5yrs |
| 取締役会の平均在任期間 | 4.5yrs |
経営陣の近況
Recent updates
The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence
Oct 28
Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares May Have Run Too Fast Too Soon
Oct 08Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns
Aug 21Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jul 29Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends
Jul 11Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected
Jun 22There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings
Jun 05Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 27Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Feb 22Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price
Feb 05Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jan 03We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt
Nov 30Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital
Nov 12Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Aug 28Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Aug 10Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly
Jul 02Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
May 01Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)
Jan 23Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Dec 27Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Oct 28Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value
Oct 13Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet
Sep 28Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Jul 24A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital
Jul 10Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly
Jun 12A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Apr 17Fisher & Paykel Healthcare (NZSE:FPH) Could Become A Multi-Bagger
Apr 04Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Mar 06With EPS Growth And More, Fisher & Paykel Healthcare (NZSE:FPH) Is Interesting
Jan 22Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention
Dec 26Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Dec 05This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation
Aug 11Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?
Aug 01Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?
Jul 07Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jun 24CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | NZ$4m | NZ$2m | NZ$133m |
| Dec 31 2023 | n/a | n/a | NZ$197m |
| Sep 30 2023 | n/a | n/a | NZ$262m |
| Jun 30 2023 | n/a | n/a | NZ$256m |
| Mar 31 2023 | NZ$3m | NZ$2m | NZ$250m |
| Dec 31 2022 | n/a | n/a | NZ$251m |
| Sep 30 2022 | n/a | n/a | NZ$251m |
| Jun 30 2022 | n/a | n/a | NZ$314m |
| Mar 31 2022 | NZ$4m | NZ$2m | NZ$377m |
| Dec 31 2021 | n/a | n/a | NZ$449m |
| Sep 30 2021 | n/a | n/a | NZ$521m |
| Jun 30 2021 | n/a | n/a | NZ$522m |
| Mar 31 2021 | NZ$4m | NZ$2m | NZ$524m |
| Dec 31 2020 | n/a | n/a | NZ$458m |
| Sep 30 2020 | n/a | n/a | NZ$392m |
| Jun 30 2020 | n/a | n/a | NZ$339m |
| Mar 31 2020 | NZ$3m | NZ$1m | NZ$287m |
| Dec 31 2019 | n/a | n/a | NZ$260m |
| Sep 30 2019 | n/a | n/a | NZ$233m |
| Jun 30 2019 | n/a | n/a | NZ$221m |
| Mar 31 2019 | NZ$3m | NZ$1m | NZ$209m |
| Dec 31 2018 | n/a | n/a | NZ$208m |
| Sep 30 2018 | n/a | n/a | NZ$206m |
| Jun 30 2018 | n/a | n/a | NZ$198m |
| Mar 31 2018 | NZ$2m | NZ$993k | NZ$190m |
報酬と市場: Lewisの 総報酬 ($USD 2.10M ) は、 NZ市場 ($USD 4.41M ) の同様の規模の企業の平均を下回っています。
報酬と収益: Lewisの報酬は 20% 以上増加しましたが、会社の収益は過去 1 年間で 20% 以上減少しました。
CEO（最高経営責任者
Lewis Gradon (63 yo)
8.6yrs
在職期間
NZ$3,533,971
報酬
Mr. Lewis G. Gradon has been the Chief Executive Officer, Managing Director & Executive Director at Fisher & Paykel Healthcare Corporation Limited since April 1, 2016. He served as the Senior Vice Presiden...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| MD, CEO & Executive Director | 8.6yrs | NZ$3.53m | 0.098% NZ$ 21.8m | |
| Chief Financial Officer | 5.7yrs | データなし | 0.0045% NZ$ 1.0m | |
| COO & GM of Respiratory Humidification | less than a year | データなし | 0.00060% NZ$ 133.6k | |
| Vice President of Products & Technology | 8.6yrs | データなし | 0.019% NZ$ 4.2m | |
| Head of Capital Markets & Investor Relations | no data | データなし | データなし | |
| Company Secretary & General Counsel | less than a year | データなし | データなし | |
| Senior Communications & Investor Relations Manager | no data | データなし | データなし | |
| VP of Sales & Marketing and President of North America & Europe | less than a year | データなし | 0.029% NZ$ 6.4m | |
| Vice President of Human Resources | 4.1yrs | データなし | データなし | |
| Vice President of Supply Chain | 2.8yrs | データなし | データなし | |
| Vice President of Corporate | no data | データなし | データなし | |
| General Manager of Airvo Optiflow | no data | データなし | データなし |
3.5yrs
平均在職期間
経験豊富な経営陣: FPHの経営陣は 経験豊富 であると考えられます ( 3.5年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| MD, CEO & Executive Director | 8.6yrs | NZ$3.53m | 0.098% NZ$ 21.8m | |
| Non-Executive Director | 23yrs | NZ$188.15k | 0.15% NZ$ 34.2m | |
| Independent Chairman of the Board | 6yrs | NZ$220.74k | 0.0013% NZ$ 282.8k | |
| Independent Non-Executive Director | 3.1yrs | NZ$212.77k | 0.0023% NZ$ 514.4k | |
| Member of EcoDesign Advisory Board | no data | データなし | データなし | |
| Non-Executive Director | less than a year | データなし | データなし | |
| Non-Executive Independent Director | 1.1yrs | NZ$93.48k | 0.00032% NZ$ 71.3k | |
| Independent Non-Executive Director | 7.4yrs | NZ$179.08k | 0.00065% NZ$ 144.7k | |
| Independent Non-Executive Director | 2.4yrs | NZ$160.13k | 0.00033% NZ$ 73.5k | |
| Member of EcoDesign Advisory Board | no data | データなし | データなし | |
| Member of EcoDesign Advisory Board | no data | データなし | データなし | |
| Member of EcoDesign Advisory Board | no data | データなし | データなし |
4.5yrs
平均在職期間
63yo
平均年齢
経験豊富なボード: FPHの 取締役会 は 経験豊富 であると考えられます ( 4.5年の平均在任期間)。